[K15, R16, L27]VIP (1-7) /GRF (8-27) (acetate)

[K15, R16, L27]VIP (1-7) /GRF (8-27) (acetate) is the acetate of [K15, R16, L27]VIP (1-7) /GRF (8-27) (HY-P4195) . [K15, R16, L27]VIP (1-7) /GRF (8-27) (acetate), a VIP1 selective agonist, exhibits IC50 values of binding of 2 nM, 1 nM, 30,000 nM for the human VIP1, rat VIP1, rat VIP2 receptors, respectively[1]. VIP: VASOACTIVE Intestinal Polypeptide

Product Specifications

UNSPSC

12352209

Target

IPK Superfamily

Type

Peptides

Related Pathways

Metabolic Enzyme/Protease; PI3K/Akt/mTOR

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/k15-r16-l27-vip-1-7-grf-8-27-acetate.html

Purity

99.50

Solubility

DMSO : 16.67 mg/mL (ultrasonic) |H2O : 10 mg/mL (ultrasonic)

Smiles

[C@H](CC1=CC=C(O)C=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N)=O)=O)[C@H](CC)C)=O)CC(O)=O)=O)CCC(N)=O)=O)CC(C)C)=O)CC(C)C)=O)CCCCN)=O)CCCNC(=N)N)=O)C)=O)CO)=O)CC(C)C)=O)CCCNC(=N)N)=O)CCCCN)=O)CC(C)C)=O)[C@H](C)C)=O)CCCCN)=O)CCCNC(=N)N)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC2=CC=CC=C2)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC3=CN=CN3)N)=O)CO)=O)CC(O)=O)=O)C)=O)C(C)C)=O)=O)[C@@H](C)O)=O)CC(N)=O)=O)CO)=O.xCC(O)=O